Phase II Study of Oxaliplatin in Combination With 5-Fluorouracil (5-FU) and Folinic Acid (FA) in Patients Who Have Failed First-Line Treatment for Locally Advanced or Metastatic Cervical Cancer.

Trial Profile

Phase II Study of Oxaliplatin in Combination With 5-Fluorouracil (5-FU) and Folinic Acid (FA) in Patients Who Have Failed First-Line Treatment for Locally Advanced or Metastatic Cervical Cancer.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 16 Sep 2009

At a glance

  • Drugs Fluorouracil; Folinic acid; Oxaliplatin
  • Indications Cervical cancer
  • Focus Therapeutic Use
  • Sponsors Sanofi
  • Most Recent Events

    • 16 Nov 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top